Cyclerion Therapeutics, Inc. Gains 35.71%
Mon, Feb 03, 2025 at 07:31 PM
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) rocketted at $5.32, a gain of 35.7%. On Mon, Feb 03, 2025, CYCN:NASDAQ touched a New 2-Week High of $5.32. From Tue, Jan 21, 2025, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Wed, Dec 04, 2024 at $9.47 with a volume of 141M+.
About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.
Top 10 Gainers:
- Invivyd Inc. (IVVD:NASDAQ), 196.34%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 192.31%
- HCW Biologics Inc. (HCWB:NASDAQ), 128.58%
- MDJM LTD (UOKA:NASDAQ), 83.08%
- GH Research PLC (GHRS:NASDAQ), 69.72%
- Singularity Future Technology Ltd. (SGLY:NASDAQ), 65.34%
- Society Pass Incorporated (SOPA:NASDAQ), 59.87%
- Reborn Coffee Inc. (REBN:NASDAQ), 54.24%
- Calidi Biotherapeutics Inc. (CLDI:NYSEMKT), 38.49%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 35.71%